Category Archives: Astrazeneca

Once-Weekly Tanzeum for Type 2s Now Available

Tanzeum (albiglutide), a once-weekly injectable drug for type 2s from GSK (GlaxoSmithKline), USA is now available at pharmacies throughout the United States. The FDA approved U.S. sales on April 15.

The drug is a glucagon-like peptide-1 receptor agonist (GLP-1) that …

FDA Delays Final OK for Type 2 Drug Empagliflozin

The FDA will delay allowing the type 2 drug empagliflozin to enter the U.S. market until “previously observed deficiencies” at the plant where it is manufactured are fixed.

The delay does not call into question the safety or utility of …

Dapagliflozin Teams Well With Metformin, Sulfonylurea

According to researchers, dapagliflozin, a diabetes drug developed jointly by two pharmaceutical companies has shown significant benefits when teamed with metformin and sulfonylurea.

The drug, already available in Europe, is produced by Bristol-Myers and AstraZeneca. It has been shown to …